Company Analysis

Aldeyra Therapeutics, Inc. (ALDX)

Nasdaq: ALDX · Pharmaceutical Preparations · Lexington, MA · filing with the SEC since 2005
Grade6.5
◀ Past 6.9● Present 6.1▶ Future 6.6
6 est.

Filings

298 filings since 2017 beside 171 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Apr 27, 2026.

Filings a yearinsider forms included
5346445242543836
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Jun 10, 2026.SEC letters: 2 in the last 36 months, the newest Apr 22, 2024.
Insider forms 171

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 SCHEDULE 13G/A Large holder update, amended
Nov 9, 2026 8-K item 8.01 Other event · Current report
Nov 6, 2026 SCHEDULE 13G Large holder notice
Nov 5, 2026 10-Q Quarterly report Sep 30, 2026
Sep 29, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Aug 12, 2026 SCHEDULE 13G Large holder notice
Aug 6, 2026 10-Q Quarterly report Jun 30, 2026
Jul 30, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Jul 28, 2026
Jul 27, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 15, 2026 8-K item 8.01 Other event · Current report Jul 14, 2026
Jun 10, 2026 8-K items 5.02, 5.07, 7.01, 9.01 Officer or director change; Shareholder vote; Investor disclosure (Regulation FD) · Current report Jun 9, 2026
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 7, 2026 10-Q Quarterly report Mar 31, 2026
May 1, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Apr 27, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 27, 2026 DEFA14A Extra proxy material
Apr 27, 2026 DEF 14A Proxy statement Jun 10, 2025
Apr 20, 2026 8-K item 5.02 Officer or director change · Current report
Apr 1, 2026 8-K item 8.01 Other event · Current report
Mar 26, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 17, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Feb 27, 2026 S-8 Employee stock plan registration
Feb 27, 2026 10-K Annual report Dec 31, 2025
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Dec 31, 2025 8-K item 5.02 Officer or director change · Current report Dec 23, 2025
Dec 16, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report Dec 15, 2025
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 13, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Nov 5, 2025 10-Q Quarterly report Sep 30, 2025
Oct 28, 2025 8-K items 8.01, 9.01 Other event · Current report
Aug 19, 2025 8-K item 9.01 Financial statements and exhibits · Current report
Aug 14, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 7, 2025 10-Q Quarterly report Jun 30, 2025
Jul 17, 2025 8-K items 8.01, 9.01 Other event · Current report
Jun 26, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Jun 17, 2025 8-K items 8.01, 9.01 Other event · Current report
Jun 11, 2025 8-K item 5.07 Shareholder vote · Current report Jun 10, 2025
May 14, 2025 10-Q Quarterly report Mar 31, 2025
May 6, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report May 5, 2025
Apr 25, 2025 ARS Annual report to shareholders Dec 31, 2024
40 of 298 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ALDX · research, not advice